Literature DB >> 11404225

Role of the human V1 vasopressin receptor COOH terminus in internalization and mitogenic signal transduction.

M Thibonnier1, C L Plesnicher, K Berrada, L Berti-Mattera.   

Abstract

We studied the role played by the intracellular COOH-terminal region of the human arginine vasopressin (AVP) V1-vascular receptor (V1R) in ligand binding, trafficking, and mitogenic signal transduction in Chinese hamster ovary cells stably transfected with the human AVP receptor cDNA clones that we had isolated previously. Truncations, mutations, or chimeric alterations of the V1R COOH terminus did not alter ligand binding, but agonist-induced V1R internalization and recycling were reduced in the absence of the proximal region of the V(1)R COOH terminus. Coupling to phospholipase C was altered as a function of the COOH-terminal length. Deletion of the proximal portion of the V1R COOH terminus or its replacement by the V2-renal receptor COOH terminus prevented AVP stimulation of DNA synthesis and progression through the cell cycle. Mutation of a kinase consensus motif in the proximal region of the V1R COOH terminus also abolished the mitogenic response. Thus the V1R cytoplasmic COOH terminus is not involved in ligand specificity but is instrumental in receptor trafficking and facilitates the interaction between the intracellular loops of the receptor, G protein, and phospholipase C. It is absolutely required for transmission of the mitogenic action of AVP, probably via a specific kinase phosphorylation site.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404225     DOI: 10.1152/ajpendo.2001.281.1.E81

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  6 in total

1.  Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer.

Authors:  Ning Zhao; Stephanie O Peacock; Chen Hao Lo; Laine M Heidman; Meghan A Rice; Cale D Fahrenholtz; Ann M Greene; Fiorella Magani; Valeria A Copello; Maria Julia Martinez; Yushan Zhang; Yehia Daaka; Conor C Lynch; Kerry L Burnstein
Journal:  Sci Transl Med       Date:  2019-06-26       Impact factor: 17.956

2.  Vasopressin up-regulates the expression of growth-related immediate-early genes via two distinct EGF receptor transactivation pathways.

Authors:  Lida Q Fuentes; Carlos E Reyes; José M Sarmiento; Carolina I Villanueva; Carlos D Figueroa; Javier Navarro; Carlos B González
Journal:  Cell Signal       Date:  2008-05-25       Impact factor: 4.315

3.  A C-terminal segment of the V1R vasopressin receptor is unstructured in the crystal structure of its chimera with the maltose-binding protein.

Authors:  Nallini Vijayarangan Adikesavan; Syed Saad Mahmood; Nithianantham Stanley; Zhen Xu; Nan Wu; Marc Thibonnier; Menachem Shoham
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-03-24

4.  Molecular variation in AVP and AVPR1a in New World monkeys (Primates, Platyrrhini): evolution and implications for social monogamy.

Authors:  Dongren Ren; Kelvin R Chin; Jeffrey A French
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

Review 5.  A review of the nonpressor and nonantidiuretic actions of the hormone vasopressin.

Authors:  Gaurang P Mavani; Maria V DeVita; Michael F Michelis
Journal:  Front Med (Lausanne)       Date:  2015-03-24

6.  Multiplexed profiling of GPCR activities by combining split TEV assays and EXT-based barcoded readouts.

Authors:  Sabrina Galinski; Sven P Wichert; Moritz J Rossner; Michael C Wehr
Journal:  Sci Rep       Date:  2018-05-25       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.